#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myxofibrosarcoma Adenovirus infection Hypomagnesaemia Cryoglobulinaemia Krabbe's disease Malignant fibrous histiocytoma Astrocytoma Idiopathic pulmonary fibrosis T-cell type acute leukaemia Demyelination Ischaemic stroke Primary amyloidosis Myelodysplastic syndrome ROHHAD syndrome Neuroblastoma recurrent More trials…

    Learn about Rare Diseases

    Pituitary-dependent Cushing’s syndrome – Life with Disease Congenital hypotransferrinaemia Brain stem glioma Chondrosarcoma – Basic Information Friedreich’s ataxia – Basic Information Idiopathic inflammatory myopathy – Basic Information Congenital hypotransferrinaemia – Trials in Disease Prader-Willi syndrome – Diagnostics CADASIL – Diagnostics Immunodeficiency congenital – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Treprostinil F44/10 Keto-Isoleucine Calcium Dornase Alfa Indometacin ZILUCOPLAN ALENDRONATE SODIUM TRIHYDRATE Metolazone Triglycerides, Medium Chain Valproate Semisodium Pegcetacoplan Terbinafine Biotin Semaglutide Granisetron Nebivolol Ublituximab Clemizole Hydrochloride Liquid Paraffin HYDROXYCHLOROQUINE More therapies…

    Learn about Your Condition

    Ankylosing spondylitis Graves' disease Liver disorder Ventricular extrasystoles Cancer pain Laryngeal cancer stage II Femoral hernia Fibrosarcoma metastatic Behavioural addiction Tympanic membrane perforation Friedreich's ataxia Breast cancer stage IV Primary myelofibrosis Chronic sinusitis Hairy cell leukaemia recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Investigative Techniques

  • Study on Pain Relief After Breast Cancer Surgery Using Ropivacaine Hydrochloride and Alfentanil in Healthy Volunteers

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    Denmark

  • Study on [18F]Fluoro-PEG-Folate PET Scans for Identifying Rheumatoid Arthritis Risk in Individuals with ACPA Positive Arthralgia

    Not recruiting

    2 1 1
    Investigated Drugs:
    • [18F]Fluoro-Peg-Folate
    The Netherlands

  • Study on the Effects of Tacrolimus on Blood Sugar Levels in Patients Undergoing Dialysis Before Kidney Transplantation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemodialysis
    Investigated Drugs:
    • Tacrolimus
    France

  • Study on Improving Pain Relief After Surgery Using Tramadol and Dexketoprofen Based on Genetic Testing for Patients with Acute Postoperative Pain

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Dexketoprofen Trometamol
    • Metamizole Magnesium
    • Tramadol Hydrochloride
    Spain

  • Study on the Use of Hyperpolarized Xenon (129Xe) and Gadobutrol for Imaging in Patients with Progressive Fibrosing Interstitial Lung Diseases

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Xenon (129Xe)
    • Gadobutrol
    Denmark

  • Study of 68Ga Satoreotide Trizoxetan PET/CT in Patients with High-Grade Neuroendocrine Lung Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neuroendocrine tumour of the lung
    Investigated Drugs:
    • Satoreotide Trizoxetan Gallium Ga-68
    Denmark
Previous Page
1 … 5 6 7

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!